C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/04 (2006.01) A61K 31/506 (2006.01) A61K 31/5377 (2006.01) C07D 401/14 (2006.01) C07D 403/14 (2006.01)
Patent
CA 2690653
The invention provides compounds and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, and methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of Alk, Ab1, Aurora-A, B-Raf, C-Raf, Bcr-Abl, BRK, Blk, Bmx, BTK, C-Kit, CSK, C-Src, EphB1, EphB2, EphB4, FLT1, Fms, Flt3, Fyn, FRK3, JAK2, KDR, Lck, Lyn, PDGFR.alpha., PDGFR.beta., PKC.alpha., SAPK2.alpha., Src, SIK, Syk, Tie2 and TrkB kinases.
La présente invention concerne des composés et leurs compositions pharmaceutiques, qui se révèlent utiles en tant qu'inhibiteurs de protéine kinase, ainsi que des procédés d'utilisation de tels composés pour traiter, améliorer ou prévenir une pathologie associée à une activité kinase anormale ou déréglée. Selon certains modes de réalisations, la présente invention concerne des procédés d'utilisation desdits composés pour traiter, améliorer ou prévenir des maladies ou des troubles qui impliquent une activation anormale des kinases Alk, Abl, Aurora-A, B-Raf, C-Raf, Bcr-Abl, BRK, Blk, Bmx, BTK, C-Kit, CSK, C-Src, EphB1, EphB2, EphB4, FLT1, Fms, Flt3, Fyn, FRK3, JAK2, KDR, Lck, Lyn, PDGFRa, PDGFRß, PKCa, SAPK2a, Src, SIK, Syk, Tie2 et TrkB.
Albaugh Pamela A.
Huang Shenlin
Liu Zuosheng
Pan Shifeng
Wang Xing
Fetherstonhaugh & Co.
Irm Llc
LandOfFree
Protein kinase inhibitors and methods for using thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protein kinase inhibitors and methods for using thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein kinase inhibitors and methods for using thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1442316